Cor Vasa 2021, 63(5):627-629 | DOI: 10.33678/cor.2021.114

(Expert consensus statement on the significance of iron deficiency and the possibilities of its correction in patients with heart failure)

Vojtěch Melenovskýa, Miloš Táborskýb, Aleš Linhartc, Jan Malíkd, Filip Máleke, Radek Pudilf, Jan Krejčíg, Michal Širanecc
a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha
b I. interní kardiologická klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc
c II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
d III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
e Kardiologické oddělení, Nemocnice Na Homolce, Praha
f I. interní kardioangiologická klinika, Univerzita Karlova - Lékařská fakulta v Hradci Králové a Fakultní nemocnice Hradec Králové, Hradec Králové
g I. interní kardioangiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice u sv. Anny v Brně, Brno

Received: September 23, 2021; Accepted: September 26, 2021; Published: October 20, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Melenovský V, Táborský M, Linhart A, Malík J, Málek F, Pudil R, et al.. (Expert consensus statement on the significance of iron deficiency and the possibilities of its correction in patients with heart failure). Cor Vasa. 2021;63(5):627-629. doi: 10.33678/cor.2021.114.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. van der Meer P, van der Wal HH, Melenovsky V. Mitochondrial Function, Skeletal Muscle Metabolism, and Iron Deficiency in Heart Failure. Circulation 2019;139:2399-2402. Go to original source... Go to PubMed...
    2. Melenovsky V, Petrak J, Mracek T, et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail 2017;19:522-530. Go to original source... Go to PubMed...
    3. van der Wal HH, Grote Beverborg N, Dickstein K, et al. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J 2019;40:3616-3625. Go to original source... Go to PubMed...
    4. Lewis GD, Malhotra R, Hernandez AF, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA 2017;317:1958-1966. Go to original source... Go to PubMed...
    5. SPC Ferinject: https://www.sukl.cz/modules/medication/detail.php?code=0192372&tab=texts
    6. Anker SD, Comin Colet J, Filippatos G, et al. FAIR-HF Trial: Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448. Go to original source... Go to PubMed...
    7. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. CONFIRM-HF Trial: Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 2015;36:657-668. Go to original source... Go to PubMed...
    8. Ponikowski P, Kirwan BA, Anker SD, et al.; AFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 2020;396:1895-1904. Go to original source... Go to PubMed...
    9. Khan MS, Usman MS, von Haehling S, et al. Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis. ESC Heart Fail 2020;7:3392-3400. Go to original source... Go to PubMed...
    10. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016;37:2129-2200. Go to original source... Go to PubMed...
    11. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-3726. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes